Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Filgotinib for moderately to severely active ulcerative colitis	Filgotinib (GLPG-0634; filgotinib maleate)	Ulcerative colitis	Gastroenterology	2019	View \| Download
Filgotinib for treating moderately to severely active Crohn's disease	Filgotinib (GLPG-0634; filgotinib maleate)	Crohn's disease	Gastroenterology , Immunology	2022	View \| Download
Finerenone for chronic kidney disease in patients with type 2 diabetes mellitus	Finerenone (BAY 948862)	Diabetic nephropathy	Endocrine Nutritional and Metabolic Disorders , Nephrology	2020	View \| Download
Finerenone for treating heart failure	Finerenone (BAY 948862)	Heart failure (HF)	Cardiovascular System	2024	View \| Download
Fingolimod (Gilenya) oral formulation for multiple sclerosis in paediatric patients (aged 10 – 17 years)	Fingolimod (Gilenya; FTY720; fingolimod hydrochloride)	Multiple sclerosis (MS)	Neurology	2017	View \| Download
Fordadistrogene movaparvovec for Duchenne muscular dystrophy	Fordadistrogene movaparvovec	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2022	View \| Download
Forigerimod plus Standard of Care for Systemic Lupus Erythematosus	Forigerimod acitate (Lupuzor. IPP-201101; CEP-33457)	Systemic lupus erythematosus (SLE)	Immunology , Nephrology	2018	View \| Download
Fosdenopterin for molybdenum cofactor deficiency type A	Fosdenopterin	Molybdenum cofactor deficiency Type A	Endocrine Nutritional and Metabolic Disorders	2023	View \| Download
Fostemsavir for HIV-1 infection for heavily treatment-experienced adults	Fostemsavir (GSK3684934; BMS-663068)	HIV-1 infection	Infectious Disease	2019	View \| Download
Fremanezumab for chronic and episodic migraine	Fremanezumab (TEV-48125; Ajovy)	Migraine	Neurology	2017	View \| Download